ID

29806

Beschreibung

Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4); ODM derived from: https://clinicaltrials.gov/show/NCT00923897

Link

https://clinicaltrials.gov/show/NCT00923897

Stichworte

Versionen (1)
  1. 20.04.18 20.04.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

20. April 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hepatocellular Carcinoma NCT00923897

Englisch

Eligibility Hepatocellular Carcinoma NCT00923897

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with hepatocellular carcinoma or hepatic metastases from a solid malignancy, unsuitable for radical therapy (including resection, transplant, conformal high dose radiotherapy), confirmed by biopsy or imaging
Beschreibung

Liver carcinoma Biopsy | Secondary malignant neoplasm of liver Solid tumour Biopsy | Liver carcinoma Imaging | Secondary malignant neoplasm of liver Solid tumour Imaging | Neoplasms Inappropriate Radical therapy | Excision | Transplantation | Conformal Radiotherapy High dose

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2239176
UMLS CUI [1,2]
C0005558
UMLS CUI [2,1]
C0494165
UMLS CUI [2,2]
C0280100
UMLS CUI [2,3]
C0005558
UMLS CUI [3,1]
C2239176
UMLS CUI [3,2]
C0011923
UMLS CUI [4,1]
C0494165
UMLS CUI [4,2]
C0280100
UMLS CUI [4,3]
C0011923
UMLS CUI [5,1]
C0027651
UMLS CUI [5,2]
C1548788
UMLS CUI [5,3]
C0260176
UMLS CUI [6]
C0728940
UMLS CUI [7]
C0040732
UMLS CUI [8,1]
C0600521
UMLS CUI [8,2]
C0444956
symptoms of hepatic pain, discomfort, nausea, or fatigue requiring palliation
Beschreibung

Symptoms Liver pain Requirement Palliative Care | Symptoms Discomfort Requirement Palliative Care | Symptoms Nausea Requirement Palliative Care | Symptoms Fatigue Requirement Palliative Care

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1457887
UMLS CUI [1,2]
C0522067
UMLS CUI [1,3]
C1514873
UMLS CUI [1,4]
C0030231
UMLS CUI [2,1]
C1457887
UMLS CUI [2,2]
C0231218
UMLS CUI [2,3]
C1514873
UMLS CUI [2,4]
C0030231
UMLS CUI [3,1]
C1457887
UMLS CUI [3,2]
C0027497
UMLS CUI [3,3]
C1514873
UMLS CUI [3,4]
C0030231
UMLS CUI [4,1]
C1457887
UMLS CUI [4,2]
C0015672
UMLS CUI [4,3]
C1514873
UMLS CUI [4,4]
C0030231
kps>60
Beschreibung

Karnofsky Performance Status

Datentyp

boolean

Alias
UMLS CUI [1]
C0206065
expected survival of greater than 3 months
Beschreibung

Life Expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
platelet count > 25 bil/l, hemoglobin > 70 g/l, inr<3, bilirubin<100 umol/l, ast < 350 u/l or alt< 400 u/l
Beschreibung

Platelet Count measurement | Hemoglobin measurement | International Normalized Ratio | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0032181
UMLS CUI [2]
C0518015
UMLS CUI [3]
C0525032
UMLS CUI [4]
C1278039
UMLS CUI [5]
C0201899
UMLS CUI [6]
C0201836
have signed an informed consent form approved by the research ethics board (reb) at princess margaret hospital
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
chemotherapy or novel drug within the past 2 weeks
Beschreibung

Chemotherapy | Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0013230
tace(transarterial chemoembolization)within the past 1 month
Beschreibung

Transarterial Chemoembolization

Datentyp

boolean

Alias
UMLS CUI [1]
C3539919
plan for active treatment of the hepatocellular carcinoma or hepatic metastases, including tace or rfa or etoh injection
Beschreibung

Therapeutic procedure Planned Liver carcinoma | Therapeutic procedure Planned Secondary malignant neoplasm of liver | Transarterial Chemoembolization | Radiofrequency ablation | Percutaneous ethanol injection therapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1301732
UMLS CUI [1,3]
C2239176
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C1301732
UMLS CUI [2,3]
C0494165
UMLS CUI [3]
C3539919
UMLS CUI [4]
C0850292
UMLS CUI [5]
C1535909
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Hepatocellular Carcinoma NCT00923897

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Liver carcinoma Biopsy | Secondary malignant neoplasm of liver Solid tumour Biopsy | Liver carcinoma Imaging | Secondary malignant neoplasm of liver Solid tumour Imaging | Neoplasms Inappropriate Radical therapy | Excision | Transplantation | Conformal Radiotherapy High dose
Item
patients with hepatocellular carcinoma or hepatic metastases from a solid malignancy, unsuitable for radical therapy (including resection, transplant, conformal high dose radiotherapy), confirmed by biopsy or imaging
boolean
C2239176 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C0494165 (UMLS CUI [2,1])
C0280100 (UMLS CUI [2,2])
C0005558 (UMLS CUI [2,3])
C2239176 (UMLS CUI [3,1])
C0011923 (UMLS CUI [3,2])
C0494165 (UMLS CUI [4,1])
C0280100 (UMLS CUI [4,2])
C0011923 (UMLS CUI [4,3])
C0027651 (UMLS CUI [5,1])
C1548788 (UMLS CUI [5,2])
C0260176 (UMLS CUI [5,3])
C0728940 (UMLS CUI [6])
C0040732 (UMLS CUI [7])
C0600521 (UMLS CUI [8,1])
C0444956 (UMLS CUI [8,2])
Symptoms Liver pain Requirement Palliative Care | Symptoms Discomfort Requirement Palliative Care | Symptoms Nausea Requirement Palliative Care | Symptoms Fatigue Requirement Palliative Care
Item
symptoms of hepatic pain, discomfort, nausea, or fatigue requiring palliation
boolean
C1457887 (UMLS CUI [1,1])
C0522067 (UMLS CUI [1,2])
C1514873 (UMLS CUI [1,3])
C0030231 (UMLS CUI [1,4])
C1457887 (UMLS CUI [2,1])
C0231218 (UMLS CUI [2,2])
C1514873 (UMLS CUI [2,3])
C0030231 (UMLS CUI [2,4])
C1457887 (UMLS CUI [3,1])
C0027497 (UMLS CUI [3,2])
C1514873 (UMLS CUI [3,3])
C0030231 (UMLS CUI [3,4])
C1457887 (UMLS CUI [4,1])
C0015672 (UMLS CUI [4,2])
C1514873 (UMLS CUI [4,3])
C0030231 (UMLS CUI [4,4])
Karnofsky Performance Status
Item
kps>60
boolean
C0206065 (UMLS CUI [1])
Life Expectancy
Item
expected survival of greater than 3 months
boolean
C0023671 (UMLS CUI [1])
Platelet Count measurement | Hemoglobin measurement | International Normalized Ratio | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
platelet count > 25 bil/l, hemoglobin > 70 g/l, inr<3, bilirubin<100 umol/l, ast < 350 u/l or alt< 400 u/l
boolean
C0032181 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0525032 (UMLS CUI [3])
C1278039 (UMLS CUI [4])
C0201899 (UMLS CUI [5])
C0201836 (UMLS CUI [6])
Informed Consent
Item
have signed an informed consent form approved by the research ethics board (reb) at princess margaret hospital
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Chemotherapy | Investigational New Drugs
Item
chemotherapy or novel drug within the past 2 weeks
boolean
C0392920 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Transarterial Chemoembolization
Item
tace(transarterial chemoembolization)within the past 1 month
boolean
C3539919 (UMLS CUI [1])
Therapeutic procedure Planned Liver carcinoma | Therapeutic procedure Planned Secondary malignant neoplasm of liver | Transarterial Chemoembolization | Radiofrequency ablation | Percutaneous ethanol injection therapy
Item
plan for active treatment of the hepatocellular carcinoma or hepatic metastases, including tace or rfa or etoh injection
boolean
C0087111 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C2239176 (UMLS CUI [1,3])
C0087111 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C0494165 (UMLS CUI [2,3])
C3539919 (UMLS CUI [3])
C0850292 (UMLS CUI [4])
C1535909 (UMLS CUI [5])
Zum Seitenanfang zurückkehren 

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video